Publications by authors named "Rowan Kuiper"

Claim this Profile
A
Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study.
Xinhe Shan, Rowan Kuiper, Chuling Ding, Pashna N Munshi, Edward A Stadtmauer

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.
Noa Biran, Binod Dhakal, Ruben Niesvizky, Suzanne Lentzsch, Divaya Bhutani, Rowan Kuiper

Br J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay.
Rowan Kuiper, Victoria J Wright, Dominic Habgood-Coote, Chisato Shimizu, Daphne Huigh

Pediatr Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H J van der Velden

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials.
Yan-Ting Chen, Erik T Valent, Erik H van Beers, Rowan Kuiper, Stefania Oliva

Int J Lab Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma.
Pim Mutsaers, Hayri E Balcioglu, Rowan Kuiper, Dora Hammerl, Rebecca Wijers

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma.
Christie P M Verkleij, Marloes E C Broekmans, Mark van Duin, Kristine A Frerichs, Rowan Kuiper

Blood Adv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma.
Erik H van Beers, Daphne Huigh, Lizanne Bosman, Leonie de Best, Rowan Kuiper

J Mol Diagn· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial.
Rowan Kuiper, Sonja Zweegman, Mark van Duin, Martin H van Vliet, Erik H van Beers

Blood Adv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Molly Went, Ben Kinnersley, Amit Sud, David C Johnson, Niels Weinhold, Rowan Kuiper

Hum Genomics· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.
Molly Went, Amit Sud, Asta Försti, Britt-Marie Halvarsson, Niels Weinhold, Rowan Kuiper

Nat Commun· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.
Molly Went, Amit Sud, Helen Speedy, Nicola J Sunter, Asta Försti, Rowan Kuiper

Blood Cancer J· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.
Molly Went, Amit Sud, Asta Försti, Britt-Marie Halvarsson, Niels Weinhold, Rowan Kuiper

Nat Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
Erik H van Beers, Martin H van Vliet, Rowan Kuiper, Leonie de Best, Kenneth C Anderson

Clin Lymphoma Myeloma Leuk· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma.
Florence Magrangeas, Rowan Kuiper, Hervé Avet-Loiseau, Wilfried Gouraud, Catherine Guérin-Charbonnel

Clin Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.
Jonathan S Mitchell, Ni Li, Niels Weinhold, Asta Försti, Mina Ali, Rowan Kuiper

Nat Commun· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System.
Rowan Kuiper, Mark van Duin, Martin H van Vliet, Annemiek Broijl, Bronno van der Holt

Blood· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue.
Ping Wu, Brian A Walker, Annemiek Broyl, Martin Kaiser, David C Johnson, Rowan Kuiper

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance.
Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari

Blood· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients.
Sophie L Corthals, Rowan Kuiper, David C Johnson, Pieter Sonneveld, Roman Hajek

Haematologica· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
Annemiek Broyl, Sophie L Corthals, Joost Lm Jongen, Bronno van der Holt, Rowan Kuiper

Lancet Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can subtle changes in gene expression be consistently detected with different microarray platforms?
Paola Pedotti, Peter A C 't Hoen, Erno Vreugdenhil, Geert J Schenk, Rolf Ham Vossen, Rowan Kuiper

BMC Genomics· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis